Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04527549
Title Testing Dabrafenib and Trametinib With or Without Hydroxychloroquine in Stage IIIC or IV BRAF V600E/K Melanoma
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors ECOG-ACRIN Cancer Research Group
Indications

melanoma

Therapies

Dabrafenib + Trametinib

Dabrafenib + Hydroxychloroquine + Trametinib

Age Groups: adult | senior
Covered Countries USA

Additional content available in CKB BOOST